公开(公告)号：US20220354941A1

公开(公告)日：2022-11-10

申请号：US17854377

申请日：2022-06-30

Applicant: GLAXOSMITHKLINE BIOLOGICALS SA

Inventor： Ralph Leon BIEMANS ,  Nathalie Marie-Josephe GARCON ,  Philippe Vincent HERMAND ,  Jan POOLMAN ,  Marcelle Paulette VAN MECHELEN

IPC: A61K39/09 ,  A61K39/385 ,  A61K47/64 ,  A61K47/61

Abstract: The present invention is in the field of pneumococcal capsular saccharide conjugate vaccines. Specifically, an immunogenic composition for infants is provided comprising a multivalent Streptococcus pneumoniae vaccine comprising 2 or more capsular saccharide conjugates from different serotypes, wherein the composition comprises a serotype 22F saccharide conjugate. Such a vaccine may be used in infant populations to reduce the incidence of elderly pneumococcal disease such as exacerbations of COPD and/or IPD.